NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray bottle, Organon Pharma PTY LTD, CON-973
Product name
NASONEX aqueous nasal spray mometasone furoate 50 microgram/actuation (as monohydrate) spray bottle
Sponsor name
Organon Pharma PTY LTD
Batches
U014537
Consent start
Consent no.
CON-973
Duration
The consent is effective from 26 July 2022 until 30 November 2022 or until the relevant batch/es are exhausted.
Standard
Paragraph 8(1)(i) of Therapeutic Goods Order No. 91 – Standard for labels of prescription and related medicines (TGO 91)
Non-compliance with standard
The labels do not include the current sponsor details (Organon Pharma Pty Ltd).
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Prescription medicines